Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this trial is to determine if by structured telephone based health coaching programme supported by remote monitoring system among type 2 diabetes, coronary artery disease and heart failure patients the investigators are able to improve their quality of life as measured by the SF-36 questionnaire and reduce a value of HbA1c under 6,5 % among those type 2 diabetes patients who had elevated value of HbA1c when recruited.
RENEWING HEALTH is a project covering 9 different European States. It aims at evaluation of innovative telemedicine services using a patient-centred approach and a common rigorous assessment methodology. In 9 European regions in the implementation of health-related information and communication technologies service solutions are already operational at local level for the remote monitoring and the treatment of chronic patients suffering from diabetes,chronic obstructive pulmonary disease or cardiovascular diseases. The services are designed to give patients a central role in the management of their own diseases, fine-tuning the choice and dosage of medications, promoting compliance to treatment, and helping health care professionals to detect early signs of worsening in the monitored pathologies. Every area will designed its own real-life trial with certain common elements.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Usual Care | No Intervention |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Health coaching | Behavioral | Telephone based health coaching supported by tele-monitoring. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Health related quality of life | Health related quality of life is assessed by the SF-36 questionnaire. | 12 months |
| HbA1c change over time (participants with T2DM only) | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Medication compliance | 12 months | |
| Blood pressure reduction | 12 months | |
| Weight reduction |
Not provided
Inclusion Criteria:
Age > 18 years
Capability of filling in questionnaires in Finnish language.
Be able to use Remote Patient Monitoring System
Be able to use the devices provided
Has adequate cognitive capacities to participate
In their medical records, one or both of the following diagnoses:
a) Type 2 Diabetes, for enrolment
diagnosed over 3 months prior to the enrolment and
HbA1c > 6,5 % b) Heart Disease, for enrolment
Ischemic heart disease or
Heart Failure or
Atrial fibrillation or
Other arrhythmia
Be able to walk
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tuula Karhula, MD, PhD | South Karelia social and health district | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Etelä-Karjalan sosiaali- ja terveydenhuollon kuntayhtymä | Lappeenranta | 53100 | Finland |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 26084979 | Derived | Karhula T, Vuorinen AL, Raapysjarvi K, Pakanen M, Itkonen P, Tepponen M, Junno UM, Jokinen T, van Gils M, Lahteenmaki J, Kohtamaki K, Saranummi N. Telemonitoring and Mobile Phone-Based Health Coaching Among Finnish Diabetic and Heart Disease Patients: Randomized Controlled Trial. J Med Internet Res. 2015 Jun 17;17(6):e153. doi: 10.2196/jmir.4059. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| D003324 | Coronary Artery Disease |
| D006333 | Heart Failure |
| D001281 | Atrial Fibrillation |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 12 months |
| Activity increase | 12 months |
| Smoke cessation | 12 months |
| Alcohol use reduction | 12 months |
| Cost for the organization | 12 months |
| Satisfaction and usability of the technology and equipments. | 12 months |
| D004700 | Endocrine System Diseases |
| D003327 | Coronary Disease |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D001161 | Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
| D001145 | Arrhythmias, Cardiac |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |